Consulting

Planning, processing, research are the foundations on which we develop the four macro areas through which we elaborate our services

sviluppo-di-modelli…ICONA

Development and application of models for economic and social burden analysis, budget impact analysis, and cost-effectiveness and cost-utility analysis.

Development of economic evaluations and pharmacoeconomic investigations in the national and international healthcare context in the perspective of a valuebased approach through the elaboration or adaptation of dynamic economic models.
supporto-dossier-prezzi…ICONA

Support for the elaboration of pricing and reimbursing dossier for the market authorization of health technologies in the italian setting.

Strategic support for the definition of Value Dossier at national, regional and local health authorities.
sviluppo-di-percorso-diagnostico…ICONA

Development and evaluation of the impact of the integrated health pathway.

Bringing together different expertise for the development of integrated health pathway (PDTA, PCA, ...) elaborated at national level but adaptable to regional and local contexts in order to reduce variability in the management of patients.
progettazione-organizzazione-e…ICONA

Planning, organization and realization of scientific advisory boards and mock negotiations.

Involving of expert to combine the best available scientific evidence with the best clinical practices, taking into account the reference context and the different perspectives operating within the healthcare ecosystem.

Papers and Research

Altems Advisory develops valuable researches to face Companies, Institutions and non-profit organizations’ specific needs

icona documenti

Digital Medicine

Strumenti terapeutici innovativi per un cambio di paradigma nell’assistenza sanitaria digitale
tasto-scarica-V
icona documenti

Patient Access Network

Position Papers - I Edizione 2022/23
tasto-scarica-V
icona documenti

Budget impact of prophylactic treatment of rVIII-SingleChain in moderate and severe hemophilia A in Italy

Increasing the usage of rVIII-SingleChain for the prophylactic treatment of hemophilia A in Italy over 3 years may lead to cost savings with uncompromised efficacy in bleed protection, according to a budget impact analysis based on real-world data
tasto-scarica-V
icona documenti

Report HTA inebilizumab (NMOSD)

Analisi multidimensionale (HTA) di inebilizumab in pazienti con disturbi dello spettro della neuromielite ottica (NMOSD) sieropositivi per le immunoglobuline G anti-aquaporina-4 (IgG AQP4) in Italia
tasto-scarica-V

These concepts are critical components of our research ensuring that new health technologies are adapted efficiently, timely and in a sustainable manner